This Healthcare Stock Is Trading Lower By 29%: Here Are 29 Stocks Moving Premarket

Loading...
Loading...

Gainers

  • Plus Therapeutics, Inc. PSTV shares rose 88.7% to $1.04 in pre-market trading after the company was awarded $17.6 million from State of Texas for continued development of co.'s lead investigational targeted radiotherapeutic Rhenium-186 NanoLiposome for the treatment of patients with leptomeningeal metastases.
  • Codiak BioSciences, Inc. CDAK shares rose 42.4% to $3.29 in pre-market trading. Codiak BioSciences recently posted a Q2 loss of $0.30 per share.
  • Wolfspeed, Inc. WOLF rose 20.7% to $103.40 in pre-market trading after the company reported better-than-expected Q4 results.
  • Vinco Ventures, Inc. BBIG rose 16.6% to $1.62 in pre-market trading after jumping 23% on Wednesday.
  • bluebird bio, Inc. BLUE shares rose 13.5% to $7.70 in pre-market trading. The FDA has approved Bluebird bio’s Zynteglo (betibeglogene autotemcel), also known as beti-cel, a one-time gene therapy custom-designed for beta‑thalassemia.
  • Corbus Pharmaceuticals Holdings, Inc. CRBP rose 13.1% to $0.2425 in pre-market trading after declining 12% on Wednesday. Corbus Pharmaceuticals recently posted a Q2 loss of $0.11 per share.
  • Applied DNA Sciences, Inc. APDN rose 12.9% to $4.19 in pre-market trading after climbing 11% on Wednesday. Applied DNA Sciences recently posted a Q3 loss of $0.13 per share.
  • Endo International plc ENDP rose 10.2% to $0.3128 in pre-market trading after dipping 23% on Wednesday. Endo International filed for bankruptcy after reaching a $6 billion deal with some of its creditors as the company sought to settle opioid-related lawsuits.
  • Privia Health Group, Inc. PRVA rose 9.7% to $39.40 in pre-market trading. Privia Health, last week, said Q2 EPS results were higher year over year.
  • Fate Therapeutics, Inc. FATE rose 9.4% to $33.06 in pre-market trading after declining 8% on Wednesday.
  • Mind Medicine (MindMed) Inc. MNMD shares rose 9.4% to $0.8195 in pre-market trading after gaining 10% on Wednesday. Mind Medicine recently posted a Q2 loss of $0.04 per share.
  • Grindrod Shipping Holdings Ltd. GRIN rose 9.3% to $20.95 in pre-market trading. Grindrod Shipping reported a second-quarter revenue increase of 47.1% year-over-year to $161.58 million.
  • Palisade Bio, Inc.PALI rose 9.2% to $0.1780 in pre-market trading after dropping 21% on Wednesday. Palisade Bio dosed first patient in its Phase 3 study evaluating lead asset LB1148 to accelerate the return of bowel function in adult patients undergoing gastrointestinal surgery.
  • Performance Shipping Inc. PSHG rose 9.1% to $0.3380 in pre-market trading after declining 13% on Wednesday. Performance Shipping recently priced its 33 million share offering at $0.45 per share.
  • Jupiter Wellness, Inc. JUPW shares rose 9.1% to $0.70 in pre-market trading. Jupiter Wellness recently reported a second-quarter FY22 sales jump of 400% year-on-year, to $3 million, versus $0.6 million last year..
  • Verb Technology Company, Inc. VERB rose 8.2% to $0.53 in pre-market trading. Verb Technology recently reported Q2 total digital revenue of $2.2 million.
  • Ultragenyx Pharmaceutical Inc. RARE rose 5.7% to $49.94 in pre-market trading. Ultragenyx reported inducement grant under Nasdaq Listing Rule 5635(c)(4).
  • Keysight Technologies, Inc. KEYS rose 4.4% to $176.72 in pre-market trading as the company reported upbeat earnings for its third quarter and issued a strong forecast for the fourth quarter.
  • Cisco Systems, Inc. CSCO rose 4.2% to $48.62 in pre-market trading after the company reported better-than-expected results for its fourth quarter and issued strong guidance.


Don’t forget to check out our premarket coverage here .

Losers

  • Unity Biotechnology, Inc. UBX shares fell 29.1% to $0.6879 in pre-market trading after the company reported pricing of upsized underwritten public offering.
  • Cedar Realty Trust, Inc. CDR fell 29.2% to $20.51 in pre-market trading. Cedar Realty Trust recently posted Q2 FFO of $0.58.
  • FedNat Holding Company FNHC fell 25% to $0.30 in pre-market trading after jumping over 15% on Wednesday.
  • Blue Water Vaccines, Inc. BWV fell 19.5% to $6.15 in pre-market trading. Blue Water Vaccines shares jumped around 200% on Wednesday after the company announced it plans to explore the potential development of a novel monkeypox vaccine using its norovirus shell and protrusion virus-like particle platform.
  • Bed Bath & Beyond Inc. BBBY fell 11.3% to $20.48 in pre-market trading after GameStop chairman Ryan Cohen filed a Form 144 with the SEC showing intent to sell his stake in the struggling retailer.
  • TDH Holdings, Inc. PETZ shares fell 10.5% to $3.81 in pre-market trading after jumping 38% on Wednesday.
  • Kirkland's, Inc. KIRK fell 10.5% to $5.70 in pre-market trading. The company is scheduled to report Q2 results on August 30, 2022.
  • Tiziana Life Sciences Ltd TLSA fell 6.9% to $0.68 in pre-market trading. Tiziana Life Sciences recently announced purchase of 200,000 common shares by executive chairman.
  • Vacasa, Inc. VCSA fell 5.7% to $4.80 in pre-market trading after declining over 8% on Wednesday. Vacasa recently reported better-than-expected Q2 sales results and issued FY22 revenue guidance above estimates.
  • Hut 8 Mining Corp. HUT fell 5.1% to $2.84 in pre-market trading after the company launched at-the-market equity program of up to $200 million.
Loading...
Loading...
Posted In: NewsPenny StocksSmall CapPre-Market OutlookMarketsMoversTrading IdeasPremarket MoversTop Gainers
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...